Bruno Soares – CEO, Coimbra Genomics, Portugal

Coimbra Genomics aims to make genetics easier. The company has developed Elsie, a digital platform that helps make better individualized clinical decisions. They have recently been recognized as the ‘second biggest promise in European e-Health’. Bruno Soares shares the Coimbra Genomics story, plans and exciting news for 2018, and how Elsie could be the solution that speeds the adoption of genomic based medicine. Could you please introduce Coimbra Genomics to our international readers?
"Our mission is to improve patient healthcare by bringing high quality and validated genomic knowledge into everyday clinical practice."
Become a PharmaBoardroom Member for free to access this content
Join the 35,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report